Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China · Delayed Price · Currency is CNY 14.82
+0.04 (0.27%)
Sep 30, 2026, 3:04 PM CST
SHE:300519 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,371 | 2,384 | 2,123 | 2,651 | 2,506 | 3,230 | |
Market Cap Growth | -4.88% | 12.28% | -19.92% | 5.81% | -22.44% | 26.27% |
Enterprise Value | 1,639 | 1,693 | 1,454 | 1,957 | 1,801 | 2,555 |
Last Close Price | 14.82 | 14.59 | 12.72 | 15.39 | 14.12 | 17.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 38.02 | 43.98 | 42.14 | 41.20 | 23.03 | 28.27 |
PS Ratio | 8.88 | 8.98 | 7.93 | 9.81 | 7.13 | 10.07 |
PB Ratio | 2.86 | 2.85 | 2.56 | 3.14 | 2.92 | 3.82 |
P/TBV Ratio | 2.89 | 2.88 | 2.58 | 3.17 | 2.95 | 3.87 |
P/FCF Ratio | 26.51 | 36.42 | 44.02 | 71.07 | 22.82 | 25.31 |
P/OCF Ratio | 26.38 | 34.59 | 39.74 | 49.75 | 19.82 | 22.69 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 6.14 | 6.38 | 5.43 | 7.24 | 5.12 | 7.96 |
EV/EBITDA Ratio | 21.24 | 27.67 | 30.95 | 30.75 | 14.42 | 21.02 |
EV/EBIT Ratio | 25.96 | 36.45 | 45.38 | 40.05 | 16.25 | 23.50 |
EV/FCF Ratio | 18.33 | 25.87 | 30.14 | 52.46 | 16.41 | 20.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Debt / Equity Ratio | -0.88 | -0.85 | -0.83 | -0.83 | -0.86 | -0.85 |
Net Debt / EBITDA Ratio | -9.49 | -11.63 | -14.66 | -10.98 | -5.90 | -5.91 |
Net Debt / FCF Ratio | -8.18 | -10.88 | -14.27 | -18.74 | -6.71 | -5.63 |
Asset Turnover | 0.30 | 0.30 | 0.29 | 0.29 | 0.37 | 0.35 |
Inventory Turnover | 3.32 | 2.90 | 2.53 | 2.72 | 3.66 | 3.24 |
Quick Ratio | 16.11 | 16.17 | 9.93 | 9.21 | 8.63 | 9.79 |
Current Ratio | 16.76 | 17.16 | 10.97 | 10.19 | 9.19 | 10.45 |
Return on Equity (ROE) | 7.55% | 6.50% | 6.02% | 7.56% | 12.76% | 13.66% |
Return on Assets (ROA) | 4.48% | 3.23% | 2.18% | 3.23% | 7.33% | 7.45% |
Return on Invested Capital (ROIC) | 56.80% | 29.73% | 19.71% | 32.20% | 76.99% | 67.83% |
Return on Capital Employed (ROCE) | 7.60% | 5.50% | 3.80% | 5.70% | 12.70% | 12.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.62% | 2.27% | 2.37% | 2.43% | 4.34% | 3.54% |
FCF Yield | 3.77% | 2.74% | 2.27% | 1.41% | 4.38% | 3.95% |
Dividend Yield | 2.02% | 2.06% | 2.36% | 2.60% | 3.54% | 3.42% |
Payout Ratio | 77.40% | 88.54% | 127.01% | 124.31% | 88.22% | 84.00% |
Buyback Yield / Dilution | 2.16% | 1.91% | -1.03% | -0.54% | 0.58% | -0.83% |
Total Shareholder Return | 4.18% | 3.97% | 1.33% | 2.06% | 4.12% | 2.59% |